Why the study?
Most patients with severe MR are over 75, making open-heart surgery challenging, which has increased the popularity of minimally invasive transcatheter approaches.
A novel compact robotic transcatheter delivery system for mitral valve implantation demonstrated successful navigation and task space control in ex vivo and phantom models.
Supports preclinical robotic mitral delivery development; leaves open in vivo and clinical translation.
Mitral regurgitation (MR) is one of the most common valvular abnormalities, and the gold-standard for treatment is surgical mitral valve repair/replacement. Most patients with severe MR are over the age of 75, which makes open-heart surgery challenging. Thus, minimally invasive surgeries using transcatheter approaches are gaining popularity. This paper proposes the next generation of a robotic transcatheter delivery system for the mitral valve implant that focuses on the design of the actuation system, modeling, and task space control. The proposed actuation system is compact while still enabling bidirectional torsion, bending, and prismatic joint motion. A pulley structure is employed to actuate the torsion and bending joints using only one motor per joint in conjunction with an antagonistic passive spring to reduce tendon slack. The robotic transcatheter is also optimized to increase its stability and reduce bending deflection. An inverse kinematics model (with an optimization algorithm), singularity analysis method, and joint hysteresis and compensation model are developed and verified. Finally, a task space controller is also proposed. Experiments, including trajectory tracking and demonstrations of the robot motion in an ex vivo porcine heart and a phantom heart through a tortuous path are presented.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: